ZOLL noted that the device is intended to provide safe and effective therapy for those at risk of sudden cardiac death. Credit: sweet_tomato/Shutterstock.com.

Medical devices and related software solutions maker ZOLL has introduced its next-generation LifeVest wearable cardioverter defibrillator (WCD) in the US.

The latest device is the fifth LifeVest WCD, which secured the Food and Drug Administration (FDA) approval.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It is compatible with the recently released next-generation LifeVest garment.

ZOLL noted that the device is intended to provide safe and effective therapy for those at risk of sudden cardiac death, with high levels of patient compliance supported by data from real-world use and peer-reviewed publications.

The past three versions have integrated response buttons into the monitor, allowing conscious patients to delay needless treatment.

The two most recent versions are said to feature a touchscreen, making it easier for patients to engage with system notifications.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The current design eliminates the requirement for a separate smartphone-type device, enabling patients to interact with the system directly.

ZOLL stated that LifeVest is the only WCD that allows this direct interaction without requiring an additional device.

According to ZOLL, the number of clinicians and patients choosing the LifeVest WCD has increased, with clinical evidence supporting the use of WCDs for newly diagnosed heart failure patients with decreased ejection fraction who are at risk of sudden cardiac death.

The LifeVest garment is tailored to accommodate daily activities outside the hospital. It features lightweight, performance-inspired fabric, flat-lock stitching, plush straps, and a wide range of sizes to fit chest measurements from 26 inches to 56 inches, added the company.

ZOLL Cardiac Management Solutions president Mike Blastick said: “ZOLL is always innovating to ensure patients have protection from sudden cardiac death with a solution that seamlessly integrates into their lives outside of the hospital.

“The latest LifeVest represents the next step in our mission, combining advanced technology with patient-centred design.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact